Mitochondrial medicine

QJM: An International Journal of Medicine

Volumn 90, Issue 11, 1997, Pages 657-667

  Chinnery, P F ^a   Turnbull, D M ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; ZIDOVUDINE;

CLINICAL FEATURE; DIABETES MELLITUS; GENE MUTATION; MITOCHONDRIAL MYOPATHY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030782409     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.11.657     Document Type: Review

References (94)

1. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242(4884):1427-30.
2. Holt I, Harding AE, Morgan-Hughes JA. Deletion of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331:717-19.
3. Johns D. Mitochondrial DNA and disease. N Engl J Med 1995; 333:638-44.
4. Wallace D, Lott M, Torroni A, Brown M. Report on the committee on human mitochondrial DNA. Genome Priority Reports 1993; 1:727-57.
5. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscular Disorders 1997; 7:XIII-XVIII.
6. Maassen J, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996; 39:375-82.
7. Henderson GV, Kittner SJ, Johns DR. An incidence study of stroke secondary to MELAS in the young. Neurology 1997; 48:A403.
8. Cooper JM, Schapira AVH. Mitochondrial dysfunction in neurodegeneration. Journal of Bioenergetics Biomembranes 1997; 29:175-184.
9. Wallace DC, Shoffner JM, Trounce I, et al. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1995; 1271(1):141-51.
10. Larsson N-G, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Ann Rev Genet 1995; 29:151-78.
11. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. Journal of Bioenergetics Biomembranes 1994; 26(3):241-50.
12. Chinnery PF, Turnbull DM. The clinical features, investigation and management of patients with mitochondrial DNA defects. J Neurol Neurosurg Psychiatry 1997; in press.
13. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA. Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 1995; 118:339-57.
14. Hirano M, Ricci E, Koenigsberger MR, et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscular Disorders 1992; 2(2):125-35.
15. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61(6):931-7.
16. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome [see comments]. N Engl J Med 1989; 320(20):1293-9.
17. Howell N. Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve? J Bioenergetics Biomembranes 1997; 29:165-73.
18. Zeviani M, Fernandez-Silva P, Tiranti V. Disorders of mitochondria and related metabolism. Curr Opin Neurol 1997; 10:160-7.
19. Moraes C. Mitochondrial disorders. Curr Opin Neurol 1996; 9:369-74.
20. Johns DR. The other genome: mitochondrial DNA and disease. Nature Med 1996; 2:1065-8.
21. Tamagawa Y, Kitamura K, Higiwara H, et al. Audiologic findings in patients with a point mutation at nucleotide 3,243 of mitochondrial DNA. Ann Otol Rhinol Laryngol 1997; 106:338-42.
22. Chu C-C, Huang C-C, Fang W, Chu N-S, Pang C-Y, Wei Y-H. Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 1997; 37:110-115.
23. Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997; 49:239-45.
24. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50(11):1197-208.
25. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and stroke. Heart Dis Stroke 1993; 2(5):439-45.
26. Chinnery PF, Reading PJ, Wallis TJ, Turnbull DM. Recurrent strokes in a 34 year old male. Lancet 1997; 350:560.
27. Welch KMA, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci 1995; 134:9-14.
28. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology 1996; 46(6):1735-8.
29. Terwindt CM, Haan J, Ophoff RA, Frants RR, Ferrari MD. The quest for migraine genes. Curr Opin Neural 1997; 10:221-5.
30. Majamaa K, Turkka J, Karppa M, Winqvist S, Hassinen IE. Prevalence of the base pair 3243 mutation in mitochondrial DNA in young patients with and occipital stroke. Neurology 1997;48:A403.
31. Gerbitz K-D, van den Ouweland JMW, Maasen JA, Jaksch M. Mitochondrial diabetes: a review. Biochim Biophys Acta 1995; 1271:253-60.
32. Gerbitz K-D. Does the mitochondrial DNA play a role in the pathogenesis of diabetes? Diabetologia 1992; 35:1181-6.
33. Wallace DC. Diseases of the mitochondrial DNA. Ann Rev Biochem 1992; 61:1175-212.
34. Papadimitiou A, Hadjigeorgiou CM, Divari R, Papagalanis N, Comi C, Bresolin N. Influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre syndrome and hypoparathyroidism. Neuromuscular Disorders 1996; 6:49-53.
35. Tulinius MH, Oldfors A, Holme E, et al. Atypical presentation of multisystem disorders in two girls with mitochondrial DNA deletions. Eur J Pediatr 1995; 154(1):35-42.
36. Chen C-M, Huang C-C. Gonadal dysfunction in mitochondrial encephalomyopathies. Eur Neurol 1995; 35:281-6.
37. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Genetic counselling for patients with mitochondrial DNA defects - predicting the outcome of pregnancy based upon maternal mutant load. Neurology 1997; 48:A349.
38. St John JC, Cooke ID, Barratt CLR. Mitochondrial mutations and male infertility. Nature Med 1997; 3:124-5.
39. Leu(UUR). Lancet 1991; 338:143-7.
40. Anan R, Nakagawa M, Miyata M, et al. Cardiac involvement in mitochondrial diseases. Circulation 1995; 91:995-961.
41. Soumalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992; 340:1319-1320.
42. glycine gene. Am J Hum Genet 1994; 55:437-446.
43. Zeviani M, Mariotti C, Antozzi C, Fratta GM, Rustin P, Prelle A. OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy. Muscle Nerve 1995; 3:S170-4.
44. Nikoskelainen EK. Clinical picture of LHON. Clin Neurosci 1994; 2:115-120.
45. Leu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 1995; 118(Pt 3):721-34.
46. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutation Res 1992; 275(3-6):169-80.
47. Howard RS, Russell S, Losseff N, et al. Management of mitochondrial disease on an intensive care unit. Q J Med 1995; 88(3):197-207.
48. Morris AAM, Leonard JV, Brown CK, et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 1996; 40:25-30.
49. Cerveri I, Fanfulla F, Zoia MC, Manni R, Tartara A. Sleep disorders in neuromuscular diseases. Monaldi Arch Chest Dis 1993; 48(4):318-21.
50. Barohn RJ, Clanton T, Sahenk Z, Mendell JR. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 1990; 40(1):103-6.
51. Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsnia M, Wizer B. Respiratory failure revealing mitochondrial myopathy in adults. Chest 1992; 101(3):824-8.
52. Shoffner JM, Voljavec AS, Dixon J, Kaufman A, Wallace DC, Mitch WE. Renal amino acid transport in adults with oxidative phosphorylation diseases. Kidney Int 1995; 47(4):1101-7.
53. Szabolcs MJ, Seigle R, Shanske S, et al. Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kidney Int 1994; 45:1388-96.
54. Niaudet P, Heidet L, Munnich A, et al. Deletion of the mitochondrial DNA in a case of de Toni-Debre-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol 1994; 8(2):164-8.
55. Morris AA, Taylor RW, Birch-Machin MA, et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr Nephrol 1995; 9(4):407-11.
56. Eviatar L, Shanske S, Gauthier B, et al. Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 1990; 40:1761-3.
57. Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 1990; 116:904-10.
58. Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJ, ed. Handbook of muscle disease. New York, Marcel Dekker, 1996:479-504.
59. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44(4): 721-7.
60. Cormier-Daire V, Bonnefont J-P, Rustin P, et al. Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 1994; 124:63-70.
61. Munnich A, Rotig A, Chretien D, et al. Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis 1996; 19:521-7.
62. Casademont J, Barrientos A, Cardellach F, et al. Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their asymptomatic mother. Hum Mol Genet 1994; 3(11):1945-9.
63. Calabresi PA, Silvestri G, DiMauro S, Griggs RC. Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF [see comments]. Muscle Nerve 1994; 17(8):943-5.
64. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991; 337(8740):508-10.
65. McKenzie R, Fried MW, Sallie R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995; 333:1099-105.
66. Suomalainen A, Majander A, Wallin M, et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 1997; 48:1244-53.
67. Shoubridge EA. Autosomal dominant chronic progressive external ophthalmoplegia: a tale of two genomes. Ann Neurol 1996; 40:693-4.
68. DiMauro S, DeVivo DC. Genetic heterogeneity in Leigh syndrome. Ann Neurol 1996; 40:5-7.
69. Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993; 34(6):827-34.
70. Dahl H. Pyruvate dehydrogenase E1 alpha deficiency: males and females differ yet again. Ann Neurol 1995; 6:483-94.
71. Rotig A, Cormier V, Blanche S, Bonnefont J-P, Ledeist F. Pearson's marrow pancreas syndrome. A multisystem mitochondrial disorder of infancy. J Clin Invest 1990; 86:1601-8.
72. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990; 28(2):131-6.
73. Morris AA, Jackson MJ, Bindoff LA, Turnbull DM. The investigation of mitochondrial respiratory chain disease. J Roy Soc Med 1995; 88(4):217P-22P.
74. Shoffner JM. Maternal inheritance and the evaluation of oxidative phosphorylation diseases. Lancet 1996; 348:1283-8.
75. DiMauro S. Mitochondrial encephalomyopathies. In: Rosenberg R, Prusiner S, DiMauro S, Barchi R, Kunkel L, eds. The molecular and genetic basis of neurological disease. Boston, Butterworth-Heinemann, 1993:665-94.
76. Huang CC, Wai YY, Chu NS, et al. Mitochondrial encephalomyopathies: CT and MRI findings and correlations with clinical features, Eur Neurol 1995; 35(4):199-205.
77. Van der Knaap MS, Jakobs C, Valk J. Magnetic resonance imaging in lactic acidosis. J Inherit Metab Dis 1996; 19:535-47.
78. Johnson MA, Barron MJ. Muscle biopsy analysis. In: Lane RJM, ed. Handbook of muscle disease. New York, Marcel Dekker, 1996.
79. Taylor RW, Chinnery PF, Clark K, Lightowlers RN, Turnbull DM. Treatment of mitochondrial disease. J Bioenergetics Biomembranes 1997; 29:195-204.
80. Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 1990; 100(1-2):70-8.
81. 31P NMR study. Neurology 1989; 39:399-43.
82. Gold R, Seibel P, Reinelt G, et al. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. Eur Neurol 1996; 36:191-6.
83. Matthews PM, Ford B, Dandurand RJ, et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993; 43(5):884-90.
84. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Nat Acad Sci USA 1984;81(11):3529-33.
85. Bernsen PL, Cabreels FJ, Ruitenbeek W, Hamburger HL. Treatment of complex I deficiency with riboflavin. J Neurol Sci 1993; 118(2):181-7.
86. Lou HC. Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in a patient with Kearns-Sayre syndrome. Arch Neurol 1981; 38:598-602.
87. DeStefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL. Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45:1193-8.
88. Tein I, DiMauro S, Xie ZW, De Vivo DC. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 1993; 34(3):281-7.
89. Lauwers MH, Van Lerseberghe C, Camu F. Inhalation anaesthesia in the Kearns-Sayre syndrome. Anesthesia 1994; 49:876-8.
90. Degoul F, Francois D, Diry M, et al. A near homoplasmic T8993G mtDNA mutation in a patient with atypic Leigh syndrome not present in mother's tissues. J Inherit Metab Dis 1997; 20:49-53.
91. Seibel P, Trappe J, Villani G, Klopstock T, Papa S, Reichmann H. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res 1995; 23:10-17.
92. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genetics 1997; 15:212-15.
93. Clark K, Bindoff LA, Lightowlers RN, et al. Correction of a mitochondrial DNA defect in human skeletal muscle. Nature Genetics 1997; 16:222-4.
94. Bradbury J. Lateral thinking suggests a way to reverse mitochondrial muscle disease. Lancet 1997; 350:119.